(2) The osmotic natriuresis, diuretic, and blood volume-reducing effects of SGLT2 inhibitors, particularly when used in combination with diuretics, may result in a relative insufficiency of effective blood volume in T2DM patients, thereby increasing the risk of AKI (42). Here, SLC5A2 is linked to acute kidney injury.